Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

Mikaela Sjöstrand,Cheryl Wei,William Cook,Kristina Johnsson,Pia S. Pollack,Christina Stahre,Boaz Hirshberg

Assessment of Saxagliptin Efficacy: Meta-Analysis of 14 Phase 2 and 3 Clinical Trials

2017

Mikaela Sjöstrand
Cheryl Wei
William Cook
Kristina Johnsson
Pia S. Pollack
Christina Stahre
Boaz Hirshberg

Introduction This meta-analysis of data from 14 phase 2 and 3, double-blind, randomized, controlled 12- and 24-week studies (N = 4632) summarizes saxagliptin efficacy in patients with type 2 diabetes (T2D) across treatment regimens.

Keywords:

Saxagliptin
Clinical trial
Type 2 diabetes
Medicine
Internal medicine
Meta-analysis
Endocrinology
in patient
Diabetes mellitus
Text mining
treatment regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations